* Home
    * Discovery Engines
    * Team
    * 
    * Portfolio
    * Offices
    * News

    News

    Versant Press ReleasesPortfolio Press ReleasesMedia Coverage

        Jan 28, 2025

        Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions

          Download PDF
          read more

        Dec 04, 2024

        Antag Therapeutics Announces €80 Million Series A Financing

          Download PDF
          read more

        Nov 21, 2024

        Versant Ventures Unveils Pep2Tango Therapeutics Inc.

          Download PDF
          read more

        Aug 22, 2024

        Versant Ventures and Novartis Launch Borealis Biosciences With $150 Million in Funding

          Download PDF
          read more

        Jun 13, 2024

        Santa Ana Bio Launches With $168 Million to Advance Precision Medicines for Inflammatory Diseases

          Download PDF
          read more

        May 22, 2024

        SixPeaks Bio AG Debuts With $110 Million in Funding

          Download PDF
          read more

        Feb 15, 2024

        Firefly Bio Debuts With $94 Million Series A Financing

          Download PDF
          read more

        Jul 26, 2023

        Nexo Therapeutics Launches With $60 Million Series A Financing

          Download PDF
          read more

        Apr 20, 2023

        Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer

          Download PDF
          read more

        Jan 04, 2023

        Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas

          Download PDF
          read more

        Jan 04, 2023

        Belharra Therapeutics Debuts With $130 Million in Funding

          Download PDF
          read more

        Oct 06, 2022

        Nested Therapeutics Launches With $125 Million Financing

          Download PDF
          read more

        Aug 10, 2022

        Versant Ventures Launches Vector BioPharma AG

          Download PDF
          read more

        Jul 27, 2022

        Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies

          Download PDF
          read more

        Apr 13, 2022

        Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A

          Download PDF
          read more

        Apr 13, 2022

        LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics

          Download PDF
          read more

        Oct 14, 2021

        Tentarix Biotherapeutics Emerges with $50 Million Series A

          Download PDF
          read more

        Sep 21, 2021

        858 Therapeutics Launches with Proven Team and $60 Million Series A Financing

          Download PDF
          read more

        Sep 09, 2021

        iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases

          Download PDF
          read more

        Sep 09, 2021

        Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures

          Download PDF
          read more

        Aug 25, 2021

        Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders

          Download PDF
          read more

        Aug 05, 2021

        Versant Ventures Announces Acquisition of Portfolio Company Vividion Therapeutics

          Download PDF
          read more

        Jun 17, 2021

        LENZ Therapeutics Debuts With $47 Million Series A Financing

          Download PDF
          read more

        Jun 15, 2021

        RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer

          Download PDF
          read more

        Jun 15, 2021

        CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia

          Download PDF
          read more

        Jun 10, 2021

        Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors

          Download PDF
          read more

        Jun 03, 2021

        Stablix Therapeutics Launches with $63 Million Series A Financing

          Download PDF
          read more

        Apr 29, 2021

        Capsida Biotherapeutics Debuts with $140 Million of Capital

          Download PDF
          read more

        Apr 21, 2021

        Versant Ventures Raises $950 Million Across Three Vehicles

          Download PDF
          read more

        Mar 03, 2021

        Century Therapeutics Completes $160 Million Series C Financing to Accelerate Development of iPSC-derived Cell Therapy Pipeline

          Download PDF
          read more

        Feb 24, 2021

        Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs

          Download PDF
          read more

        Feb 11, 2021

        Pipeline Therapeutics Completes $80 Million Series C Financing

          Download PDF
          read more

        Dec 08, 2020

        RayzeBio Completes $105M Series B Financing to Advance Targeted Radiopharmaceuticals for Cancer

          Download PDF
          read more

        Oct 14, 2020

        RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics

          Download PDF
          read more

        Sep 16, 2020

        Graphite Bio Launches with $45 Million Series A Financing

          Download PDF
          read more

        Aug 06, 2020

        T-knife Completes €66 Million Series A Financing to Develop Next-Generation T-Cell Therapies

          Download PDF
          read more

        Aug 05, 2020

        Versant Ventures Launches Matterhorn Biosciences

          Download PDF
          read more

        Jul 28, 2020

        Versant Ventures Launches Bright Peak Therapeutics

          Download PDF
          read more

        Jun 09, 2020

        Versant Ventures Launches Lycia Therapeutics with $50 Million

          Download PDF
          read more

        May 26, 2020

        Monte Rosa Therapeutics Discloses $32.5 Million Financing

          Download PDF
          read more

        May 06, 2020

        Ventus Therapeutics Launches with $60 Million Series A

          Download PDF
          read more

        Mar 10, 2020

        Versant Ventures Strengthens Global Team and Discovery Engine Infrastructure

          Download PDF
          read more

        Jan 29, 2020

        Versant Ventures Announces Successful IPO by Black Diamond Therapeutics

          Download PDF
          read more

        Dec 18, 2019

        Pipeline Therapeutics Completes $30 Million Series B Financing

          Download PDF
          read more

        Sep 04, 2019

        Versant Ventures Enables Launch of Vensana Capital to Focus on Medtech Sector

          Download PDF
          read more

        Sep 04, 2019

        Repare Therapeutics Announces US$82.5 Million Series B Financing

          Download PDF
          read more

        Sep 04, 2019

        Passage Bio Closes $110 Million Series B Financing

          Download PDF
          read more

        Aug 22, 2019

        Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases

          Download PDF
          read more

        Aug 08, 2019

        Versant Ventures Announces Acquisition of Cell Therapy Company BlueRock Therapeutics

          Download PDF
          read more

        Jul 01, 2019

        Century Therapeutics Launches With USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy Platform

          Download PDF
          read more

        Jun 19, 2019

        Akero Therapeutics Announces Pricing of Initial Public Offering

          Download PDF
          read more

        May 16, 2019

        Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist

          Download PDF
          read more

        May 08, 2019

        Pfizer Acquires Clinical-Stage Biotech Therachon

          Download PDF
          read more

        Apr 30, 2019

        Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing

          Download PDF
          read more

        Feb 14, 2019

        Passage Bio Launches with $115.5 Million Series A to Develop AAV-Delivered Therapeutics to Treat Rare Monogenic CNS Diseases

          Download PDF
          read more

        Jan 09, 2019

        Black Diamond Therapeutics Closes $85 Million Series B Financing

          Download PDF
          read more

        Dec 17, 2018

        Versant Ventures Raises USD100 Million Canadian Fund

          Download PDF
          read more

        Dec 17, 2018

        Versant Ventures Raises $700 Million

          Download PDF
          read more

        Dec 12, 2018

        Akero Therapeutics Announces $70 Million in New Financing to Advance Therapeutic Pipeline for NASH, Serious Metabolic Diseases

          Download PDF
          read more

        Dec 11, 2018

        Versant Ventures Launches Black Diamond Therapeutics

          Download PDF
          read more

        Nov 27, 2018

        Genentech Acquires Jecure Therapeutics

          Download PDF
          read more

        Nov 13, 2018

        Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist

          Download PDF
          read more

        Oct 31, 2018

        Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4

          Download PDF
          read more

        Oct 10, 2018

        Gotham Therapeutics Launches with $54 Million Series A

          Download PDF
          read more

        Sep 12, 2018

        MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform

          Download PDF
          read more

        Sep 11, 2018

        Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer

          Download PDF
          read more

        Sep 04, 2018

        Tempest Therapeutics Names Dr. Ginna Laport CMO

          Download PDF
          read more

        Jun 25, 2018

        Akero Therapeutics Closes $65 Million Series A Financing to Advance New Treatments for Serious Metabolic Diseases

          Download PDF
          read more

        May 23, 2018

        Lava Therapeutics Raises EUR 16 Million to Advance Bispecific Gamma-Delta T Cell Engager Platform

          Download PDF
          read more

        Apr 12, 2018

        Enterprise Therapeutics Raises £29 Million ($41 Million USD) Funding

          Download PDF
          read more

        Apr 04, 2018

        Inception Neuroscience Program Acquired by Roche

          Download PDF
          read more

        Mar 28, 2018

        Tempest Therapeutics Closes $70 Million Series B Financing

          Download PDF
          read more

        Mar 05, 2018

        Vividion Therapeutics Announces Strategic Research Collaboration with Celgene Corporation to Discover Therapies Against Transformative, First-in-Class Targets

          Download PDF
          read more

        Feb 27, 2018

        Quentis Therapeutics Debuts with $48 Million Series A Financing to Advance First-in-Class Immunotherapies Targeting Endoplasmic Reticulum Stress Response Pathways

          Download PDF
          read more

        Jan 18, 2018

        Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs for Autoimmune and Inflammatory Diseases

          Download PDF
          read more

        Dec 14, 2017

        Jnana Therapeutics Launches With $50 Million Series A

          Download PDF
          read more

        Nov 13, 2017

        NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in Preclinical Model

          Download PDF
          read more

        Nov 09, 2017

        Northern Biologics Announces CEO Transition

          Download PDF
          read more

        Nov 07, 2017

        Versant, NEA Back Oyster Point Pharma

          Download PDF
          read more

        Nov 06, 2017

        NousCom Raises €42 Million Series B Financing

          Download PDF
          read more

        Sep 26, 2017

        FierceBiotech Names Repare Therapeutics as One of Its “Fierce 15” Biotech Companies of 2017

          Download PDF
          read more

        Sep 26, 2017

        FierceBiotech Names Gritstone Oncology as a "Fierce 15" Biotechnology Company of 2017

          Download PDF
          read more

        Sep 07, 2017

        Gritstone Oncology Secures $92.7 Million In Series B Financing

          Download PDF
          read more

        Jul 25, 2017

        VenatoRx Pharmaceuticals Raises $42 Million Series B

          Download PDF

        Jun 22, 2017

        Repare Raises US$68M Series A

          Download PDF

        Feb 28, 2017

        CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation

          Download PDF

        Feb 15, 2017

        Versant Ventures Launches Jecure Therapeutics

          Download PDF

        Feb 07, 2017

        Flexion Therapeutics Announces New Drug Application for Zilretta™ (FX006) Accepted by U.S. Food and Drug Administration

          Download PDF

        Feb 02, 2017

        Tarveda Therapeutics Raises $30 Million in Series D Financing to Advance Pentarin Miniaturized Drug Conjugates

          Download PDF

        Feb 02, 2017

        Vividion Therapeutics, Inc., Launches With $50 Million Series A Financing

          Download PDF

        Jan 05, 2017

        Versant Ventures Strengthens Global Team to Launch New $400M Fund

          Download PDF
          read more

        Jan 03, 2017

        Versant Ventures Closes Sixth Healthcare Fund

          Download PDF
          read more

        Dec 19, 2016

        Versant Ventures Announces Milestone with Recent Northern Biologics and BlueRock Therapeutics Deals

          Download PDF
          read more

        Dec 19, 2016

        Northern Biologics, Mosaic Biomedicals Execute Transformative Deal

          Download PDF

        Dec 12, 2016

        Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

          Download PDF

        Nov 02, 2016

        Versant Ventures Portfolio Company Turnstone Biologics completes CAD$55.3 million Series B

          Download PDF

        Sep 26, 2016

        Nouscom Appoints New Chief Operating Officer and Strengthens the Board of Directors

          Nouscom, an oncology company developing patient specific cancer vaccines based on a clinically validated genetic vaccine platform, today announced the appointment of Dr Marina Udier Blagovic as Chief Operating Officer (COO).
          Download PDF

        Apr 12, 2016

        Versant Ventures Strengthens Global Team

          Announces Investment Team Promotions and Additions; New Discovery Engine Appointments
          Download PDF
          read more

        Industry News is currently unavailable, please check back soon.

    Media Contact

    Steve Edelson

      (415) 801-8088
      [email protected]
    * LP Access
    * News
    * Contact Us
    * Site Map
    * Privacy
    * Terms
    © 2025 Versant Ventures. a FINE site.